{
    "clinical_study": {
        "@rank": "52205", 
        "brief_summary": {
            "textblock": "RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet\n      known if radiation therapy is effective in preventing metastatic cancer following surgery.\n\n      PURPOSE: Randomized phase III trial to determine the effectiveness of radiation therapy in\n      preventing metastatic cancer in patients who have undergone diagnostic procedures to\n      identify malignant mesothelioma."
        }, 
        "brief_title": "Radiation Therapy in Preventing Metastatic Cancer in Patients Who Have Diagnostic Procedures to Identify Malignant Mesothelioma", 
        "completion_date": {
            "#text": "December 2002", 
            "@type": "Actual"
        }, 
        "condition": [
            "Malignant Mesothelioma", 
            "Perioperative/Postoperative Complications"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Mesothelioma", 
                "Postoperative Complications"
            ]
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES:\n\n        -  Determine the efficacy of radiotherapy in the prevention of metastatic skin nodules or\n           tumor seeding following invasive diagnostic procedures, such as chest drain insertion,\n           pleural aspiration, pleural biopsy, and thoracoscopy, in patients with malignant\n           mesothelioma.\n\n        -  Determine whether the nodules that develop after radiotherapy are symptomatic in these\n           patients.\n\n        -  Compare the quality of life of patients treated with radiotherapy vs standard care\n           alone.\n\n      OUTLINE: This is a randomized study.\n\n      Patients are randomized to 1 of 2 treatment arms.\n\n        -  Arm I: Patients receive radiotherapy on 3 consecutive days beginning within 3 weeks\n           after chest drain insertion, pleural aspiration, pleural biopsy, or thoracoscopy and\n           once the wounds have healed.\n\n        -  Arm II: Patients receive standard supportive care alone. Quality of life is assessed at\n           baseline, and then at 1, 2, 4, 6, 9, and 12 months.\n\n      Patients are followed at 1, 2, 4, 6, 9, and 12 months.\n\n      PROJECTED ACCRUAL: A total of 44 patients (22 per arm) will be accrued for this study within\n      2 years."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS:\n\n          -  Histologically proven malignant pleural mesothelioma by chest drain insertion,\n             pleural aspiration, pleural biopsy, and/or thoracoscopy within the past 3 weeks\n\n        PATIENT CHARACTERISTICS:\n\n        Age:\n\n          -  Not specified\n\n        Performance status:\n\n          -  Not specified\n\n        Life expectancy:\n\n          -  At least 3 months\n\n        Hematopoietic:\n\n          -  Not specified\n\n        Hepatic:\n\n          -  Not specified\n\n        Renal:\n\n          -  Not specified\n\n        PRIOR CONCURRENT THERAPY:\n\n        Biologic therapy:\n\n          -  Not specified\n\n        Chemotherapy:\n\n          -  No prior systemic chemotherapy for malignant mesothelioma\n\n        Endocrine therapy:\n\n          -  Not specified\n\n        Radiotherapy:\n\n          -  No prior local radiotherapy for malignant mesothelioma\n\n        Surgery:\n\n          -  See Disease Characteristics\n\n          -  No other invasive procedures to the same chest site during and for 1 year after study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "44", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 11, 2000", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00006231", 
            "org_study_id": "CDR0000068155", 
            "secondary_id": [
                "CRC-BOC-L52", 
                "EU-20033"
            ]
        }, 
        "intervention": [
            {
                "intervention_name": "quality-of-life assessment", 
                "intervention_type": "Procedure"
            }, 
            {
                "intervention_name": "standard follow-up care", 
                "intervention_type": "Procedure"
            }, 
            {
                "intervention_name": "radiation therapy", 
                "intervention_type": "Radiation"
            }
        ], 
        "keyword": [
            "localized malignant mesothelioma", 
            "advanced malignant mesothelioma", 
            "perioperative/postoperative complications"
        ], 
        "lastchanged_date": "December 18, 2013", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/CRC-BOC-L52"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Glasgow", 
                        "country": "United Kingdom", 
                        "state": "Scotland", 
                        "zip": "G12 0YN"
                    }, 
                    "name": "Gartnavel General Hospitall"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Glasgow", 
                        "country": "United Kingdom", 
                        "state": "Scotland", 
                        "zip": "G21 3UW"
                    }, 
                    "name": "Stobhill General Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Glasgow", 
                        "country": "United Kingdom", 
                        "state": "Scotland", 
                        "zip": "G11 6NT"
                    }, 
                    "name": "West of Scotland Cancer Centre"
                }
            }
        ], 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "official_title": "A Randomized Study to Assess Whether Radiotherapy Prevents Skin Lumps at Sites Where Needles or Tubes Have Been Inserted in Patients With Malignant Mesothelioma", 
        "overall_official": {
            "affiliation": "University of Glasgow", 
            "last_name": "Noelle O'Rourke, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 3", 
        "primary_outcome": {
            "measure": "Incidence of metastatic skin nodules", 
            "safety_issue": "No"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00006231"
        }, 
        "results_reference": {
            "citation": "O'Rourke N, Paul J, Hill J: Radiotherapy to mesothelioma drain sites may not be worthwhile: interim report of a randomized study. Lung Cancer 29(1 Suppl 1): A-568, 168, 2000."
        }, 
        "source": "National Cancer Institute (NCI)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Glasgow", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 1998", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2000"
    }, 
    "geocoordinates": {
        "Gartnavel General Hospitall": "55.864 -4.252", 
        "Stobhill General Hospital": "55.864 -4.252", 
        "West of Scotland Cancer Centre": "55.864 -4.252"
    }
}